Next Article in Journal
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
Previous Article in Journal
The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach
 
 
Article

Article Versions Notes

Cancers 2022, 14(2), 345; https://doi.org/10.3390/cancers14020345
Action Date Notes Link
article xml file uploaded 11 January 2022 15:02 CET Original file -
article xml uploaded. 11 January 2022 15:02 CET Update -
article pdf uploaded. 11 January 2022 15:02 CET Version of Record https://www.mdpi.com/2072-6694/14/2/345/pdf-vor
article supplementary file uploaded. 11 January 2022 15:02 CET - https://www.mdpi.com/2072-6694/14/2/345#supplementary
article html file updated 11 January 2022 15:03 CET Original file -
article xml file uploaded 18 January 2022 05:28 CET Update -
article xml uploaded. 18 January 2022 05:28 CET Update https://www.mdpi.com/2072-6694/14/2/345/xml
article pdf uploaded. 18 January 2022 05:28 CET Updated version of record https://www.mdpi.com/2072-6694/14/2/345/pdf
article html file updated 18 January 2022 05:29 CET Update -
article html file updated 31 July 2022 03:15 CEST Update https://www.mdpi.com/2072-6694/14/2/345/html
Back to TopTop